Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Czobor

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Hospital & Community Psychiatry|May 1, 1992
Assessment of risk behaviors for HIV infection among psychiatric inpatientsJ Volavka, A Convit, J O'Donnell, et al.
Psychiatry Research|November 26, 1998
Change in plasma prolactin and clinical response to haloperidol in schizophrenia and schizoaffective disorderJ C Chou, R Douyon, P Czobor, et al.
Psychiatry Research|November 1, 1991
HIV seroprevalence and risk behaviors in psychiatric inpatientsJ Volavka, A Convit, P Czobor, et al.
Psychological Medicine|August 21, 2008
Attention deficit hyperactivity disorder (ADHD): gender- and age-related differences in neurocognitionS Bálint, P Czobor, S Komlósi, et al.
Schizophrenia Bulletin|July 23, 1999
Symptomatic overlap of cocaine intoxication and acute schizophrenia at emergency presentationM R Serper, J C Chou, M H Allen, et al.
Psychopharmacology Bulletin|January 1, 1990
Haloperidol blood levels and effects in schizophrenia and schizoaffective disorder: a progress reportJ Volavka, T B Cooper, M Meisner, et al.
Schizophrenia Research|July 15, 2010
Executive function in deficit schizophrenia: what do the dimensions of the Wisconsin Card Sorting Test tell us?P Polgár, J M Réthelyi, S Bálint, et al.
The Annals of Pharmacotherapy|October 1, 1993
Pharmacoepidemiology of clozapine in 202 inpatients with schizophreniaJ M Zito, J Volavka, T J Craig, et al.
The Annals of Pharmacotherapy|December 1, 1996
Neuroleptics in acute mania: a pharmacoepidemiologic studyJ C Chou, J M Zito, J Vitrai, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|December 15, 2015
Hostility in schizophrenia: An integrated analysis of the combined Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and the European First Episode Schizophrenia Trial (EUFEST) studiesJ Volavka, R A Van Dorn, L Citrome, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Hospital & Community Psychiatry|May 1, 1992
Assessment of risk behaviors for HIV infection among psychiatric inpatientsJ Volavka, A Convit, J O'Donnell, et al.
Psychiatry Research|November 26, 1998
Change in plasma prolactin and clinical response to haloperidol in schizophrenia and schizoaffective disorderJ C Chou, R Douyon, P Czobor, et al.
Psychiatry Research|November 1, 1991
HIV seroprevalence and risk behaviors in psychiatric inpatientsJ Volavka, A Convit, P Czobor, et al.
Psychological Medicine|August 21, 2008
Attention deficit hyperactivity disorder (ADHD): gender- and age-related differences in neurocognitionS Bálint, P Czobor, S Komlósi, et al.
Schizophrenia Bulletin|July 23, 1999
Symptomatic overlap of cocaine intoxication and acute schizophrenia at emergency presentationM R Serper, J C Chou, M H Allen, et al.
Psychopharmacology Bulletin|January 1, 1990
Haloperidol blood levels and effects in schizophrenia and schizoaffective disorder: a progress reportJ Volavka, T B Cooper, M Meisner, et al.
Schizophrenia Research|July 15, 2010
Executive function in deficit schizophrenia: what do the dimensions of the Wisconsin Card Sorting Test tell us?P Polgár, J M Réthelyi, S Bálint, et al.
The Annals of Pharmacotherapy|October 1, 1993
Pharmacoepidemiology of clozapine in 202 inpatients with schizophreniaJ M Zito, J Volavka, T J Craig, et al.
The Annals of Pharmacotherapy|December 1, 1996
Neuroleptics in acute mania: a pharmacoepidemiologic studyJ C Chou, J M Zito, J Vitrai, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|December 15, 2015
Hostility in schizophrenia: An integrated analysis of the combined Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and the European First Episode Schizophrenia Trial (EUFEST) studiesJ Volavka, R A Van Dorn, L Citrome, et al.
Pageof 6